Navigation Links
USAID Provides Malaria Assistance to Zimbabwe
Date:2/6/2009

WASHINGTON, Feb. 6 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) continues to provide assistance to the people of Zimbabwe, who are in the midst of an expanding humanitarian crisis. An ailing economy, food shortages and the cholera epidemic have left the people of Zimbabwe in danger of other health risks.

USAID, through the President's Malaria Initiative, is supporting emergency Indoor Residual Spraying (IRS) to shore up gaps in the country's usually strong spraying efforts. While the country retains adequate stocks of malaria drugs, less than half of the usual level of indoor mosquito spraying has occurred. The program will reach 20 districts that would have otherwise gone without this integral malaria protection mechanism. The Ministry of Health in Zimbabwe has stated that this accelerated program will avert 4 million cases and will save 3,000 to 4,000 lives.

The timing of this intervention is vitally important as it will cover a large portion of the population just in time for the season of highest malaria transmittance. Malaria cases in Zimbabwe begin to rise in February and peak in April and May.

Indoor Residual Spraying shortens the lifetime of mosquitoes that carry the malaria parasite. When a mosquito lands in a home that has been sprayed, the mosquito is killed or its life is shortened so that it cannot pass parasites from one person to another.

USAID provided emergency funding of $200,000 along with the UK's Department for International Development's (DFID) providing 200,000 pounds Sterling to enable the National Malaria Control Program to launch a two-month "Accelerated IRS" program in February and March, before peak transmission in April and May. The two responded immediately, procuring equipment, mobilizing teams and transport, and disbursing equipment for approximately 821 spray operators.

For more information about USAID's malaria programs visit: http://www.usaid.gov/our_work/global_health/id/malaria/index.html and http://pmi.gov/.

The American people, through the U.S. Agency for International Development, have provided economic and humanitarian assistance worldwide for nearly 50 years.

Public Information: 202-712-4810


'/>"/>
SOURCE U.S. Agency for International Development
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
2. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
3. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
4. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
5. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
6. Raptor Pharmaceuticals Provides Update of Product Programs
7. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
8. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
9. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
10. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
11. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Feb. 9, 2016 On Tuesday, ... (FDA) met with its Arthritis Advisory Committee ... of Johnson & Johnson,s Remicade and most ... in the U.S. The Biologics Prescribers Collaborative ... - Alliance for Patient Access, American Association ...
(Date:2/10/2016)... 2016 Demonstrates changes in ... receptor selectivity   1 receptor ... entered clinical development as a new treatment for ...   --> 1 receptor agonist, ... clinical development as a new treatment for cognitive ...
(Date:2/9/2016)... Corporation (NASDAQ: PODD ) (Insulet or the Company), the ... OmniPod ® Insulin Management System, today announced ... Insulet,s Board of Directors. With his appointment, the Board is ... --> --> Mr. Lemoine ... a deep knowledge of accounting, financial reporting and internal controls ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. ... office is now offering a variety of comprehensive procedures for facial enhancement. The ... facial volume restoration, lip enhancement and nasal reshaping. , As a result, ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Ongoing news of ... Life Care Association™ (ALCA) to conduct a survey that takes a closer look at ... today illustrates the prevalence and causes of TBI among the aging population, and identifies ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors (UBA), ... latest addition to its growing list of Partner Firms. S.S. Nesbitt is ... Orlando to Huntsville and in between. , Harnessing the experience and insights of ...
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... time Emmy award winner and inspirational speaker Jan Fox will serve as keynote ... Speaking Boldly will provide participants with tools to more effectively communicate with their ...
Breaking Medicine News(10 mins):